Troriluzole

DB15079InvestigationalSmall molecule

Troriluzole is under investigation in clinical trial NCT03701399 (Troriluzole in Adult Subjects With Spinocerebellar Ataxia).

Chemical structure of Troriluzole
Formula / weight
C15H16F3N5O4S · 419.38 g/mol (avg)
Code names
BHV-4157

Resolves to

Compound
UNIIS7H48S6K7HCAS1926203-09-9ChEMBLCHEMBL4297586
Clinical / RWD
ATCN07XX23
Structure
InChIKeyYBZSGIWIPOUSHY-UHFFFAOYSA-NSMILESCN(CC(=O)NC1=NC2=C(S1)C=C(OC(F)(F)F)C=C2)C(=O)CNC(=O)CN

What you can answer from here — as of September 21, 2026

14Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1ATC codeIncluding every combination product, plus 1 drug category
Sign in

Which companies are running trials of Troriluzole, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In